Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HSBC Holdings | 1.74% | $15.08M | HK$2.12T | 51.25% | 80 Outperform | |
| Barclays | 1.47% | $12.71M | £65.06B | 77.33% | 78 Outperform | |
| Novartis AG | 1.30% | $11.28M | CHF209.54B | 23.96% | 80 Outperform | |
| GlaxoSmithKline | 1.28% | $11.08M | £72.84B | 34.49% | 77 Outperform | |
| Standard Chartered | 1.25% | $10.80M | £40.86B | 100.92% | 77 Outperform | |
| ING GROEP | 1.17% | $10.13M | €70.27B | 60.28% | 61 Neutral | |
| Roche Holding AG | 0.99% | $8.57M | CHF263.28B | 43.76% | 73 Outperform | |
| ― | 0.98% | $8.54M | ― | ― | ― | |
| AstraZeneca | 0.95% | $8.21M | £211.99B | 30.73% | 80 Outperform | |
| ArcelorMittal | 0.94% | $8.15M | €28.58B | 72.58% | 73 Outperform |